These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23929102)

  • 1. Induction of cellular senescence by oncogenic RAS.
    Gupta R; Wajapeyee N
    Methods Mol Biol; 2013; 1048():127-33. PubMed ID: 23929102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
    Pantoja C; Serrano M
    Oncogene; 1999 Sep; 18(35):4974-82. PubMed ID: 10490832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts.
    Castro ME; del Valle Guijarro M; Moneo V; Carnero A
    J Cell Biochem; 2004 Jun; 92(3):514-24. PubMed ID: 15156563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence.
    Kodama R; Kato M; Furuta S; Ueno S; Zhang Y; Matsuno K; Yabe-Nishimura C; Tanaka E; Kamata T
    Genes Cells; 2013 Jan; 18(1):32-41. PubMed ID: 23216904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Oncogene-Induced Senescence In Vivo.
    Baek KH; Ryeom S
    Methods Mol Biol; 2017; 1534():185-198. PubMed ID: 27812880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence.
    Li H; Wang W; Liu X; Paulson KE; Yee AS; Zhang X
    Oncogene; 2010 Sep; 29(36):5083-94. PubMed ID: 20581871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducing cellular senescence using defined genetic elements.
    Nakagawa H; Opitz OG
    Methods Mol Biol; 2007; 371():167-78. PubMed ID: 17634581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.
    Neault M; Mallette FA; Richard S
    Cell Rep; 2016 Mar; 14(8):1966-78. PubMed ID: 26904954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell analysis of p16(INK4a) and p21(WAF1) expression suggests distinct mechanisms of senescence in normal human and Li-Fraumeni Syndrome fibroblasts.
    Mirzayans R; Andrais B; Scott A; Paterson MC; Murray D
    J Cell Physiol; 2010 Apr; 223(1):57-67. PubMed ID: 20039273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
    Peeper DS; Shvarts A; Brummelkamp T; Douma S; Koh EY; Daley GQ; Bernards R
    Nat Cell Biol; 2002 Feb; 4(2):148-53. PubMed ID: 11812999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescence of human fibroblasts induced by oncogenic Raf.
    Zhu J; Woods D; McMahon M; Bishop JM
    Genes Dev; 1998 Oct; 12(19):2997-3007. PubMed ID: 9765202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function.
    Morris M; Hepburn P; Wynford-Thomas D
    Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors.
    Horiguchi M; Koyanagi S; Okamoto A; Suzuki SO; Matsunaga N; Ohdo S
    Cancer Res; 2012 Jan; 72(2):395-401. PubMed ID: 22102693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAFE600-associated senescence-like cell cycle arrest of human naevi.
    Michaloglou C; Vredeveld LC; Soengas MS; Denoyelle C; Kuilman T; van der Horst CM; Majoor DM; Shay JW; Mooi WJ; Peeper DS
    Nature; 2005 Aug; 436(7051):720-4. PubMed ID: 16079850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular senescence induced by cathepsin X downregulation.
    Kraus S; Bunsen T; Schuster S; Cichoń MA; Tacke M; Reinheckel T; Sommerhoff CP; Jochum M; Nägler DK
    Eur J Cell Biol; 2011 Aug; 90(8):678-86. PubMed ID: 21616554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.
    Vizioli MG; Santos J; Pilotti S; Mazzoni M; Anania MC; Miranda C; Pagliardini S; Pierotti MA; Gil J; Greco A
    Oncotarget; 2014 Sep; 5(18):8270-83. PubMed ID: 25268744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression.
    Yang X; He Z; Xin B; Cao L
    Oncogene; 2000 Apr; 19(16):2002-13. PubMed ID: 10803461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.